Xenon Pharmaceuticals Inc.
DE ˙ DB ˙ CA98420N1050
45,60 € ↑1,00 (2,24%)
2026-06-04
DEL PRIS
SecurityDE:XP0 / Xenon Pharmaceuticals Inc.
InstitutionPoint72 Asset Management, L.P.
ManagerSteven Cohen
Latest Disclosed Ownership1,178,501 shares
Ownership 1.90%
Point72 Asset Management, L.P. ownership in XP0 / Xenon Pharmaceuticals Inc.

2023-02-14 - Point72 Asset Management, L.P. has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,178,501 shares of Xenon Pharmaceuticals Inc. (DE:XP0). This represents 1.9 percent ownership of the company. In their previous filing dated 2022-02-14 , Point72 Asset Management, L.P. had reported owning 3,007,138 shares, indicating a decrease of -60.81 percent.

Point72 Asset Management, L.P. has a history of taking positions in derivatives of the underlying security (XP0) in the form of stock options. The firm currently holds call options representing 9,300 of underlying shares valued at $540,795 USD and put options representing 9,300 of underlying shares valued at $540,795 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2023-02-14 2023-02-14 13G/A 3,007,138 1,178,501 -60.81 1.90 -67.24
2022-02-14 2022-02-14 13G/A 2,641,253 3,007,138 13.85 5.80 13.73
2021-10-28 2021-10-28 13G 2,641,253 5.10

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:XP0 / Xenon Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-14 2025-06-30 13F XENON PHARMACEUTICALS COM 98420N105 0 -209,759 -100.00 0 -100.00
2025-07-21 2025-03-31 13F/A-1 XENON PHARMACEUTICALS COM 98420N105 209,759 209,759 7,037 0.0161
2025-05-15 2025-03-31 13F XENON PHARMACEUTICALS COM 98420N105 209,759 209,759 7,037 0.0161
2025-02-14 2024-12-31 13F XENON PHARMACEUTICALS COM 98420N105 0 -383,290 -100.00 0 -100.00
2024-11-14 2024-09-30 13F XENON PHARMACEUTICALS COM 98420N105 383,290 -98,732 -20.48 15,090 -19.71 0.0384
2024-09-16 2024-06-30 13F/A-2 XENON PHARMACEUTICALS COM 98420N105 482,022 206,163 74.73 18,794 58.27 0.0492
2024-08-19 2024-06-30 13F/A-1 XENON PHARMACEUTICALS COM 98420N105 482,022 206,163 18,794 0.0492
2024-08-14 2024-06-30 13F XENON PHARMACEUTICALS COM 98420N105 482,022 206,163 18,794 0.0491
2024-05-15 2024-03-31 13F XENON PHARMACEUTICALS COM 98420N105 275,859 -599,206 -68.48 11,876 -70.54 0.0288
2024-02-14 2023-12-31 13F XENON PHARMACEUTICALS COM 98420N105 875,065 -250,643 -22.27 40,305 4.81 0.0975
2023-11-14 2023-09-30 13F XENON PHARMACEUTICALS COM 98420N105 1,125,708 977,500 659.55 38,454 573.92 0.1122
2023-08-14 2023-06-30 13F XENON PHARMACEUTICALS COM 98420N105 148,208 -356,416 -70.63 5,706 -68.41 0.0170
2023-05-15 2023-03-31 13F XENON PHARMACEUTICALS COM 98420N105 504,624 -673,700 -57.17 18,060 -61.13 0.0559
2023-05-15 2022-12-31 13F/A-1 XENON PHARMACEUTICALS COM 98420N105 1,178,324 -461,748 -28.15 46,461 -21.53 0.1579
2023-02-14 2022-12-31 13F XENON PHARMACEUTICALS COM 98420N105 1,178,324 -461,748 46,461 0.1579
2022-11-14 2022-09-30 13F XENON PHARMACEUTICALS COM 98420N105 1,640,072 738,566 81.93 59,207 115.89 0.2365
2022-08-15 2022-06-30 13F XENON PHARMACEUTICALS COM 98420N105 901,506 -1,244,944 -58.00 27,424 -58.21 0.1157
2022-05-16 2022-03-31 13F XENON PHARMACEUTICALS COM 98420N105 2,146,450 -846,147 -28.27 65,617 -29.81 0.2605
2022-02-14 2021-12-31 13F XENON PHARMACEUTICALS COM 98420N105 2,992,597 1,914,797 177.66 93,489 467.67 0.3733
2021-11-15 2021-09-30 13F XENON PHARMACEUTICALS COM 98420N105 1,077,800 175,500 19.45 16,469 -1.98 0.0723
2021-08-16 2021-06-30 13F XENON PHARMACEUTICALS COM 98420N105 902,300 141,299 18.57 16,801 23.34 0.0755
2021-05-17 2021-03-31 13F XENON PHARMACEUTICALS COM 98420N105 761,001 288,022 60.90 13,622 87.27 0.0636
2021-02-16 2020-12-31 13F XENON PHARMACEUTICALS COM 98420N105 472,979 25,918 5.80 7,274 46.98 0.0355
2020-11-16 2020-09-30 13F XENON PHARMACEUTICALS COM 98420N105 447,061 -212,343 -32.20 4,949 -40.15 0.0253
2020-08-14 2020-06-30 13F XENON PHARMACEUTICALS COM 98420N105 659,404 74,351 12.71 8,269 24.63 0.0539
2020-05-15 2020-03-31 13F XENON PHARMACEUTICALS COM 98420N105 585,053 -270,747 -31.64 6,635 -40.86 0.0539
2020-02-14 2019-12-31 13F XENON PHARMACEUTICALS COM 98420N105 855,800 -69,200 -7.48 11,220 34.63 0.0590
2019-11-15 2019-09-30 13F XENON PHARMACEUTICALS COM 98420N105 925,000 0 0.00 8,334 -8.63 0.0512
2019-08-14 2019-06-30 13F XENON PHARMACEUTICALS COM 98420N105 925,000 75,000 8.82 9,121 5.62 0.0477
2019-05-15 2019-03-31 13F XENON PHARMACEUTICALS COM 98420N105 850,000 125,000 17.24 8,636 88.77 0.0392
2019-02-14 2018-12-31 13F XENON PHARMACEUTICALS COM 98420N105 725,000 325,000 81.25 4,575 -13.35 0.0223
2018-11-14 2018-09-30 13F XENON PHARMACEUTICALS COM 98420N105 400,000 321,900 412.16 5,280 634.35 0.0218
2018-08-14 2018-06-30 13F XENON PHARMACEUTICALS COM 98420N105 78,100 -228,979 -74.57 719 -52.23 0.0029
2018-05-15 2018-03-31 13F XENON PHARMACEUTICALS COM 98420N105 307,079 -3,100 -1.00 1,505 71.80 0.0063
2018-02-14 2017-12-31 13F XENON PHARMACEUTICALS COM 98420N105 310,179 0 0.00 876 -4.26 0.0038
2017-11-14 2017-09-30 13F XENON PHARMACEUTICALS COM 98420N105 310,179 0 0.00 915 -6.35 0.0041
2017-08-14 2017-06-30 13F XENON PHARMACEUTICALS COM 98420N105 310,179 0 0.00 977 -21.27 0.0055
2017-05-15 2017-03-31 13F XENON PHARMACEUTICALS COM 98420N105 310,179 0 0.00 1,241 -48.03 0.0069
2017-02-14 2016-12-31 13F XENON PHARMACEUTICALS COM 98420N105 310,179 -48,352 -13.49 2,388 -17.77 0.0167
2016-11-14 2016-09-30 13F XENON PHARMACEUTICALS COM 98420N105 358,531 0 0.00 2,904 37.30 0.0204
2016-08-15 2016-06-30 13F XENON PHARMACEUTICALS COM 98420N105 358,531 0 0.00 2,115 -15.60 0.0144
2016-05-16 2016-03-31 13F XENON PHARMACEUTICALS COM 98420N105 358,531 41,146 12.96 2,506 -1.80 0.0192
2016-02-16 2015-12-31 13F XENON PHARMACEUTICALS COM 98420N105 317,385 0 0.00 2,552 -2.67 0.0210
2015-11-16 2015-09-30 13F XENON PHARMACEUTICALS COM 98420N105 317,385 50,045 18.72 2,622 -14.93 0.0206
2015-08-14 2015-06-30 13F XENON PHARMACEUTICALS COM 98420N105 267,340 157,340 143.04 3,082 66.15 0.0213
2015-05-15 2015-03-31 13F XENON PHARMACEUTICALS COM 98420N105 110,000 110,000 1,855 0.0126
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F XENON PHARMACEUTICALS COM Call 9,300 0.00 541 29.81 n/a n/a n/a
2026-02-17 2025-12-31 13F XENON PHARMACEUTICALS COM Call 9,300 417 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F XENON PHARMACEUTICALS COM Put 9,300 0.00 541 29.81 n/a n/a n/a
2026-02-17 2025-12-31 13F XENON PHARMACEUTICALS COM Put 9,300 417 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.